Spatial transcriptomics and scRNA-seq demonstrated the robust expression of estrogen receptor 1 (ESR1) and progesterone receptor (PGR) in fibroids with significant involvement of the ERK1/ERK2 pathway in mediating hormonal effects and promoting tumor progression. The gene discussed is MAPK1; the disease is neoplasm.